A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.

Mitochondria are crucial regulators of the intrinsic pathway of apoptosis. Herein, we report a photosensitizer-conjugated camptothecin (CPT)-based prodrug for combinative chemo-photodynamic treatment of solid tumors with cascade activations. Upon light irradiation, our prodrug can effectively target the mitochondria of cancer cells, generate singlet oxygen to increase the level of reactive oxygen species (ROS) and trigger ROS-responsive release of CPT, which synergistically induce mitochondrial damage and cause the apoptosis of cancer cells, therefore achieving high therapeutic efficacy for solid tumors and minimized adverse effects to normal tissues. Our prodrug holds great promise as a potent and inspiring means for cancer treatment.

[1]  C. Soto-Sánchez,et al.  Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme , 2021, Molecular Pharmaceutics.

[2]  Jiabao Hu,et al.  Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases. , 2020, Journal of medicinal chemistry.

[3]  Xiaomei Yan,et al.  Activatable Mitochondria-Targeting Organoarsenic Prodrugs for Bioenergetic Cancer Therapy. , 2020, Angewandte Chemie.

[4]  Z. Qian,et al.  ROS‐Responsive Camptothecin Prodrug Nanoparticles for On‐Demand Drug Release and Combination of Chemotherapy and Photodynamic Therapy , 2020, Advanced Functional Materials.

[5]  Chuan-Yuan Li,et al.  Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment , 2020, Cell & Bioscience.

[6]  S. Tait,et al.  Mitochondria as multifaceted regulators of cell death , 2019, Nature Reviews Molecular Cell Biology.

[7]  Xiaopeng Li,et al.  Light-Controlled Generation of Singlet Oxygen within a Discrete Dual-Stage Metallacycle for Cancer Therapy. , 2019, Journal of the American Chemical Society.

[8]  D. Xing,et al.  Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy , 2019, Nature Communications.

[9]  Mengyao Wang,et al.  Redox/pH dual‐stimuli responsive camptothecin prodrug nanogels for “on‐demand” drug delivery , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Jong Seung Kim,et al.  Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable Prodrug , 2018, Chem.

[11]  Justin J. Wilson,et al.  Characterization and Biological Activity of a Hydrogen Sulfide-Releasing Red Light-Activated Ruthenium(II) Complex. , 2018, Journal of the American Chemical Society.

[12]  C. Alexiou,et al.  ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria. , 2018, Angewandte Chemie.

[13]  M. Haigis,et al.  The multifaceted contributions of mitochondria to cellular metabolism , 2018, Nature Cell Biology.

[14]  L. Ji,et al.  A mitochondria-targeting hetero-binuclear Ir(iii)-Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells. , 2018, Chemical communications.

[15]  Jong Seung Kim,et al.  Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics. , 2018, Chemical Society reviews.

[16]  Jong Seung Kim,et al.  A Mitochondria-Targeted Cryptocyanine-Based Photothermogenic Photosensitizer. , 2017, Journal of the American Chemical Society.

[17]  Mahdi Karimi,et al.  Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light. , 2017, Journal of the American Chemical Society.

[18]  B. Li,et al.  A Red Light Activatable Multifunctional Prodrug for Image‐Guided Photodynamic Therapy and Cascaded Chemotherapy , 2016 .

[19]  K. Y. Zhang,et al.  A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia. , 2016, Angewandte Chemie.

[20]  J. Sessler,et al.  Programmed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitor , 2016, Scientific Reports.

[21]  R. Youle,et al.  The role of mitochondria in apoptosis*. , 2009, Annual review of genetics.

[22]  N. Sen,et al.  Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani , 2004, Cell Death and Differentiation.

[23]  A Khodjakov,et al.  Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells , 2000, Cell Death and Differentiation.

[24]  S. Weinberg,et al.  Targeting mitochondria metabolism for cancer therapy. , 2015, Nature chemical biology.